From: A hemodialysis cohort study of protocol-based anticoagulation management
Pre-protocol | Post-protocol | |
---|---|---|
n | 25 | 21 |
% Male/female | 64/36 | 57/43 |
Mean age (as of 11/1/2013) ± standard deviation | 70 ± 14 | 61 ± 16 |
ESRD diagnosis | ||
Diabetic nephropathy | 9 | 7 |
Hypertension | 4 | 3 |
Polycystic kidney disease | 2 | 2 |
Glomerulonephritis | 2 | 4 |
Renal artery stenosis | 2 | 1 |
Other | 6 | 4 |
Indication for warfarin | ||
Atrial fibrillation | 17 | 8 |
DVT/PE | 2 | 5 |
Mechanical cardiac valve | 1 | 2 |
Other | 5 | 6 |
INR target range | ||
2–3 | 20 | 17 |
2.5–3.5 | 4 | 3 |
Other | 1 | 1 |